Arvinas
Focus: Arvinas is a New Haven-based biotechnology company specializing in bifunctional small molecules for protein degradation, with a focused pipeline in oncology. The company operates as a mid-cap biotech with a lean clinical and research portfolio centered on the PROTAC (PROteolysis-TArgeting Chimera) platform.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Arvinas?
AI assessmentBest fit for scientists seeking deep PROTAC/protein degradation expertise and tolerance for biotech execution risk; less suitable for those prioritizing job security or rapid internal career growth.
Why Work Here
- Lead position in protein degradation science: Arvinas owns a differentiated PROTAC platform with 11 active clinical programs across oncology indications, offering deep technical expertise in an emerging modality.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ARV-471 in combination with Everolimus
Breast CancerClinical Trials (1)
NCT05501769ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
Phase 1Help build intelligence for Arvinas
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.